Answers are grounded in this paper and cite their sources.
Stroke is a serious cerebrovascular disease that can cause disability and death if not treated with appropriate treatment methods at the right time. In ischaemic stroke, recombinant tissue plasminogen activator (rt-PA) treatment is effective in motor deficit recovery, especially in the first 4.5 hours. In this case study, rt-PA thrombolytic treatment of patients with motor deficit after acute ischaemic stroke aged 58 and 79 years was found to improve the loss of motor function.
No takes yet. Share an insight, caveat, or question.
Karakoç et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: